First-Ever World Kidney Cancer Q&A Day Highlights Growing Global Burden
Kidney cancer is a silent disease that’s on the rise. The global incidence of kidney cancer is predicted to increase by a shocking 22 percent by 2020. Explanations are incomplete, but include risk factors such as ageing, obesity, high blood pressure and smoking.
The lack of answers is why the International Kidney Cancer Coalition (IKCC) and kidney cancer organisations worldwide are marking the first-ever World Kidney Cancer Q&A Day. On June 22, patients, carers, health care professionals and local organisations will be asking questions and seeking answers:
- What explains the varying incidence of kidney cancer worldwide? High incidence rates are seen in northern and eastern Europe, North America and Australia, with the highest rates estimated in the Czech Republic?
- How can we address the growing gap in mortality rates for kidney cancer between emerging and developed economies?
- How can we prevent kidney cancer, or detect it earlier when patients can still be cured?
“We need global collaboration for kidney cancer – in research, awareness and advocacy – because when we work together we have a greater impact than we do alone and can drive significant change for patients,” says Dr. Rachel Giles, Chair, IKCC.
A new paper authored by leading experts, The Global Burden of Kidney Cancer: A Call to Action (under review) underscores the challenges faced in diagnosis and disease management.
The IKCC also launched the World Kidney Cancer Day Q&A Quiz. Available in nine languages, the seven-question quiz tests what you know – and what you need to know – about kidney cancer. For every quiz completed, $5 will be directed to a high-priority research project that will benefit patients worldwide.
Great Voice, Great Cause
Globally-recognized celebrity and humanitarian Juliet Ibrahim is the campaign’s Global Ambassador.
“Just like art, kidney cancer knows no boundaries. Working together – sharing our experience and our knowledge – we make a difference for the people affected by kidney cancer,” says Juliet. The Juliet Ibrahim Foundation gives hope to kidney cancer patients throughout Africa.
World Kidney Cancer Q&A Day has been established by the IKCC (www.ikcc.org), a global body of 30 cancer organisations focused on improving the lives of people affected by kidney cancer. The campaign is supported by Bristol-Myers Squibb, Novartis, Pfizer, and Ipsen.
Reverb Consulting Group
Jilda Lazer, 1-647-290-7573
Om Business Wire
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Pharnext: First-Half 201719.10.2017 17:30 | Pressemelding
Regulatory News: Pharnext SA (FR00111911287 - ALPHA), a biopharmaceutical company pioneering a new approach to the development of innovative drugs based on the combination and repositioning of known drugs, today announced its first-half 2017 financial results. Daniel Cohen, M.D., Ph.D. Co-Founder and CEO said of activity for the first half of 2017: "Activity in the first-half of the year was very dense; we implemented two prominent strategic partnerships with the biotech company Galapagos and the Tasly Group, one of the top ten pharmaceutical companies in China. Our flagship product, PXT3003 for the treatment of Charcot-Marie-Tooth disease type 1A, is nearing the end of Phase 3, which is slated for the second half of 2018. We confirm our target of taking the product to market by 2019." A half-year marked by strategic agreements
Tickets Now on Sale for FEI World Equestrian Games Tryon 2018, North Carolina, USA, on September 11-23, 201819.10.2017 16:58 | Pressemelding
Tickets for the FEI World Equestrian GamesTM Tryon 2018 (WEG) are now on sale to the public online at www.tryon2018.com. With more than 500,000 people expected to attend the 2018 Games, the 12-day spectacle of equestrian champions is one of the biggest events on the global sporting calendar and will be the largest equestrian event in North Carolina’s history. Mark Bellissimo, CEO of host venue Tryon International Equestrian Center (TIEC) in Tryon, NC, USA, said: “Demand from the event is way beyond our expectations and it would not surprise me if this event were to sell out early. We have experienced unprecedented demand, far bigger than we ever anticipated. There is tremendous appetite for this event, so we encourage people to buy now.” Tickets for the WEG include the following options: a standard Day Pass, Individual Event Pass, All Session Discipline Pas
SFL – Third-Quarter 2017 Financial Information19.10.2017 16:30 | Pressemelding
Regulatory News: SFL (Paris:FLY): Rental income: €147.8 million, up 3.3% like-for-like Consolidated revenue by business segment (€000’s) 2017 (9 months) 2016 (9 months)
AMRA and BioTelemetry Research Raise the Standard for Medical Imaging in NASH/NAFLD Clinical Trials19.10.2017 16:04 | Pressemelding
AMRA, the international leader in body composition analysis, and BioTelemetry Research (“BTR”), a leading global imaging and cardiac core lab, announced today the formation of an exclusive alliance for non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) clinical trials. This first-to-market partnership will advance imaging science and benefit clinical trial sponsors in several musculoskeletal and metabolic therapeutic areas. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171019006110/en/ In clinical studies, muscle and fat fractions have traditionally been measured by scanning individual organs such as the liver, or particular body regions such as the abdomen. Commonly, researchers would prefer to scan the entire body in order to learn exactly where study participants are losing or gaining mu
AGCO Announces a New Data Connection with The Climate Corporation’s Climate FieldViewTM Digital Agriculture Platform19.10.2017 14:30 | Pressemelding
AGCO Corporation (NYSE:AGCO), a world-leading manufacturer and distributor of agricultural equipment, announced today a new digital partnership with The Climate Corporation, a subsidiary of Monsanto Company (NYSE:MON), that will provide AGCO customers the option to connect with The Climate Corporation’s Climate FieldView™ platform. AGCO’s partnership with The Climate Corporation is a product of Fuse and its open approach to agriculture, which focuses on helping customers optimize their farms through seamless technology integration and connectivity. “AGCO is excited to work with The Climate Corporation to give our customers yet another choice for Precision Ag solutions,” says Chris Rhodes, director Fuse Business Development. “The Climate FieldView platform is the world’s most broadly connected and adopted farm insight and visualization platform, and AGCO is pleased to be creating a tigh
Arrive Safely: Head to Tirendo and Equip Yourself Properly for Your First Winter19.10.2017 14:25 | Pressemelding
The days are getting shorter, and the thermometer is dropping. Especially for new drivers looking forward to their first winter behind the wheel, the sudden onset of snowy and icy roads can be a real challenge. Even more important, therefore, to make sure that you have the appropriate tyres for wintry driving conditions. Tirendo shares some tips on what this involves. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171019005888/en/ Head to Tirendo and equip yourself properly for your first winter - Photo source: ENZO In winter weather above all, the correct tread depth is crucial for safe driving. The legal minimum throughout Europe is 1.6 mm, however experts recommend at least 4 mm in snowy and icy conditions to ensure sufficient grip. To measure your tyre’s tread depth, simply take a two euro coin:
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom